Journal
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
Volume 14, Issue -, Pages S1227-S1229Publisher
WOLTERS KLUWER MEDKNOW PUBLICATIONS
DOI: 10.4103/0973-1482.199380
Keywords
AZD9291; drug-induced lung injury; epidermal growth factor receptor-tyrosine kinase inhibitor; interstitial lung disease; nonsmall cell lung cancer
Categories
Ask authors/readers for more resources
AZD9291 is one of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer (NSCLC). Interstitial lung disease (ILD) induced by AZD9291 is very seldom. We provide a case of NSCLC treated with AZD9291 who developed ILD and died in order to improve the knowledge on AZD9291.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
